Colorectal cancer

[1]  K. Paull,et al.  Oxaliplatin, tetraplatin, cisplatin, and carboplatin: spectrum of activity in drug-resistant cell lines and in the cell lines of the National Cancer Institute's Anticancer Drug Screen panel. , 1996, Biochemical pharmacology.

[2]  M. Roizen,et al.  Current Understanding of Patients' Attitudes Toward and Preparation for Anesthesia: A Review , 1996, Anesthesia and analgesia.

[3]  S. Kriwanek,et al.  Perforated colorectal cancer , 1996, Diseases of the colon and rectum.

[4]  J. Olsen,et al.  Randomised study of screening for colorectal cancer with faecal-occult-blood test , 1996, The Lancet.

[5]  S. Thibodeau,et al.  Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes. , 1996, Cancer research.

[6]  M. Masu,et al.  Deleted in Colorectal Cancer (DCC) Encodes a Netrin Receptor , 1996, Cell.

[7]  G. Thorgeirsson,et al.  Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study. , 1996, Archives of internal medicine.

[8]  B. Davis,et al.  The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. , 1996, The New England journal of medicine.

[9]  R. Beart,et al.  Wound recurrence following laparoscopic colon cancer resection , 1996, Diseases of the colon and rectum.

[10]  Irene L Andrulis,et al.  MADR2 Maps to 18q21 and Encodes a TGFβ–Regulated MAD–Related Protein That Is Functionally Mutated in Colorectal Carcinoma , 1996, Cell.

[11]  D. Winchester,et al.  The National Cancer Data Base report on colon cancer , 1996, Cancer.

[12]  N. Petrelli,et al.  Clinical utility of external immunoscintigraphy with the IMMU-4 technetium-99m Fab' antibody fragment in patients undergoing surgery for carcinoma of the colon and rectum: results of a pivotal, phase III trial. The Immunomedics Study Group. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  L. Layfield,et al.  Lymph node recovery from colorectal resection specimens removed for adenocarcinoma. Trends over time and a recommendation for a minimum number of lymph nodes to be recovered. , 1996, American journal of clinical pathology.

[14]  Tomoyuki Kato,et al.  Prognostic factors for patients with colon or rectal carcinoma treated with resection only: Five‐year follow‐up report , 1996, Cancer.

[15]  G. Barberio,et al.  A survival regression analysis of prognostic factors in colorectal cancer. , 1996, The Australian and New Zealand journal of surgery.

[16]  D. Haller,et al.  Phase III study of bolus versus infusion fluorouracil with or without cisplatin in advanced colorectal cancer. , 1996, Journal of the National Cancer Institute.

[17]  A. Spigelman,et al.  Colorectal polyp counts and cancer risk in familial adenomatous polyposis. , 1996, Gastroenterology.

[18]  B. Nordlinger,et al.  Surgical resection of colorectal carcinoma metastases to the liver: A prognostic scoring system to improve case selection, based on 1568 patients , 1996, Cancer.

[19]  T. Chou,et al.  Irinotecan is an active agent in untreated patients with metastatic colorectal cancer. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  H. Mulcahy,et al.  Long‐term outcome following curative surgery for malignant large bowel obstruction , 1996, The British journal of surgery.

[21]  J. Fleshman,et al.  Laparoscopic-assisted and minilaparotomy approaches to colorectal diseases are similar in early outcome , 1996, Diseases of the colon and rectum.

[22]  S. Moss,et al.  Randomised controlled trial of faecal-occult-blood screening for colorectal cancer , 1989, The Lancet.

[23]  D. Morris,et al.  Laparoscopic vs Open Ultrasound of the Liver: An in vitro Study , 1996, HPB surgery : a world journal of hepatic, pancreatic and biliary surgery.

[24]  P. H. Sugarbaker,et al.  Pseudomyxoma peritonei syndrome. , 1996, Advances in surgery.

[25]  M. Ychou,et al.  Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines. , 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

[26]  I. Russell,et al.  Single‐stage treatment for malignant left‐sided colonic obstruction: A prospective randomized clinical trial comparing subtotal colectomy with segmental resection following intraoperative irrigation , 1995, The British journal of surgery.

[27]  T R Fleming,et al.  Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  R. Nozaki,et al.  Management of early invasive colorectal cancer , 1995, Diseases of the colon and rectum.

[29]  D. Galloway,et al.  Efficacy of tumoricidal agents in vitro and in vivo , 1995, The British journal of surgery.

[30]  G A Colditz,et al.  The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. , 1995, The New England journal of medicine.

[31]  K. Kinzler,et al.  Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. , 1995, Science.

[32]  J. Silverman,et al.  Endoscopically removed malignant colorectal polyps: clinicopathologic correlations. , 1995, Gastroenterology.

[33]  J. P. Pignon,et al.  Efficacy of adjuvant fluorouracil and folinic acid in colon cancer International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators , 1995, The Lancet.

[34]  P. Johnston,et al.  Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors. , 1995, Cancer research.

[35]  K. Kinzler,et al.  The molecular basis of Turcot's syndrome. , 1995, The New England journal of medicine.

[36]  G A Colditz,et al.  Physical Activity, Obesity, and Risk for Colon Cancer and Adenoma in Men , 1995, Annals of Internal Medicine.

[37]  J. Mcgregor,et al.  Comparison of Manually Constructed and Stapled Anastomoses in Colorectal Surgery , 1995, Annals of surgery.

[38]  P. Hérait,et al.  Phase I and pharmacologic studies of the camptothecin analog irinotecan administered every 3 weeks in cancer patients. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  T. Loy,et al.  Utility of cytokeratin immunostaining in separating pulmonary adenocarcinomas from colonic adenocarcinomas. , 1994, American journal of clinical pathology.

[40]  P. Quirke,et al.  Role of circumferential margin involvement in the local recurrence of rectal cancer , 1994, The Lancet.

[41]  P. Finan,et al.  The role of CA-242 and CEA in surveillance following curative resection for colorectal cancer. , 1994, British Journal of Cancer.

[42]  L. Påhlman,et al.  Intraoperative colonic lavage and primary anastomosis--an alternative to Hartmann procedure in emergency surgery of the left colon. , 1994, The European journal of surgery = Acta chirurgica.

[43]  R. Kane,et al.  The impact of intraoperative ultrasonography on surgery for liver neoplasms. , 1994, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[44]  A. Zauber,et al.  Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. , 1993 .

[45]  H. Rockette,et al.  The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[46]  P. Sugarbaker,et al.  Evaluation of computed tomography in patients with peritoneal carcinomatosis , 1993, Cancer.

[47]  C. Willett,et al.  Postoperative radiation therapy for high-risk colon carcinoma. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[48]  L M Schuman,et al.  Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. , 1993, The New England journal of medicine.

[49]  S. Piantadosi,et al.  Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. , 1993, The New England journal of medicine.

[50]  S. Iacobelli,et al.  Oxaliplatin activity against metastatic colorectal cancer. A phase II study of 5-day continuous venous infusion at circadian rhythm modulated rate. , 1993, European journal of cancer.

[51]  A. Whittemore,et al.  Dietary intake of fiber and decreased risk of cancers of the colon and rectum: evidence from the combined analysis of 13 case-control studies. , 1992, Journal of the National Cancer Institute.

[52]  J. Pater,et al.  Systemic Infusion Versus Bolus Chemotherapy with 5‐Fluorouracil in Measurable Metastatic Colorectal Cancer , 1992, American journal of clinical oncology.

[53]  P. Quirke,et al.  The Pathologist’s Role in the Assessment of Local Recurrence in Rectal Carcinoma , 1992 .

[54]  R. Fitzgibbons,et al.  Patterns of recurrence after curative resection of carcinoma of the colon and rectum. , 1992, Surgery, gynecology & obstetrics.

[55]  P. Piedbois.  Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[56]  J. Alexander,et al.  Primary appendiceal malignancies: rare but important. , 1992, Surgery.

[57]  V. Alves,et al.  Restaging of colorectal cancer based on the identification of lymph node micrometastases through immunoperoxidase staining of CEA and cytokeratins , 1991, Diseases of the colon and rectum.

[58]  M Jacobs,et al.  Minimally invasive colon resection (laparoscopic colectomy). , 1991, Surgical laparoscopy & endoscopy.

[59]  K. Kinzler,et al.  Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. , 1991, Science.

[60]  C. McArdle,et al.  Impact of variability among surgeons on postoperative morbidity and mortality and ultimate survival. , 1991, BMJ.

[61]  G A Colditz,et al.  Relation of meat, fat, and fiber intake to the risk of colon cancer in a prospective study among women. , 1990, The New England journal of medicine.

[62]  H. Adami,et al.  Ulcerative colitis and colorectal cancer. A population-based study. , 1990, The New England journal of medicine.

[63]  B. Trock,et al.  Dietary fiber, vegetables, and colon cancer: critical review and meta-analyses of the epidemiologic evidence. , 1990, Journal of the National Cancer Institute.

[64]  J. Doroshow,et al.  Prospective randomized comparison of fluorouracil versus fluorouracil and high-dose continuous infusion leucovorin calcium for the treatment of advanced measurable colorectal cancer in patients previously unexposed to chemotherapy. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[65]  T R Fleming,et al.  Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. , 1990, The New England journal of medicine.

[66]  I. Barneto,et al.  Weekly high-dose infusion of 5-fluorouracil in advanced colorectal cancer. , 1990, European journal of cancer.

[67]  J. Laurie,et al.  Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[68]  N. Petrelli,et al.  The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study Group. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[69]  J G Fryer,et al.  A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[70]  Y. Nakamura,et al.  Genetic alterations during colorectal-tumor development. , 1988, The New England journal of medicine.

[71]  R. Collins,et al.  Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery. , 1988, The New England journal of medicine.

[72]  H. Rockette,et al.  Postoperative adjuvant chemotherapy or BCG for colon cancer: results from NSABP protocol C-01. , 1988, Journal of the National Cancer Institute.

[73]  C. Erlichman,et al.  A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[74]  A. Megibow,et al.  Carcinoma of the colon: detection and preoperative staging by CT. , 1988, AJR. American journal of roentgenology.

[75]  F. Denizot,et al.  A new member of the immunoglobulin superfamily—CTLA-4 , 1987, Nature.

[76]  J. Harvey,et al.  Pilot trial of prolonged continuous-infusion 5-fluorouracil and weekly cisplatin in advanced colorectal cancer. , 1987, Cancer treatment reports.

[77]  A. Altendorf,et al.  Multivisceral resections in colorectal cancer , 1987, Diseases of the colon and rectum.

[78]  P. Quirke,et al.  LOCAL RECURRENCE OF RECTAL ADENOCARCINOMA DUE TO INADEQUATE SURGICAL RESECTION Histopathological Study of Lateral Tumour Spread and Surgical Excision , 1986, The Lancet.

[79]  R. Heald,et al.  RECURRENCE AND SURVIVAL AFTER TOTAL MESORECTAL EXCISION FOR RECTAL CANCER , 1986, The Lancet.

[80]  R. Haggitt,et al.  Prognostic factors in colorectal carcinomas arising in adenomas: implications for lesions removed by endoscopic polypectomy. , 1985, Gastroenterology.

[81]  L. Fielding,et al.  Malignant large bowel obstruction , 1985, The British journal of surgery.

[82]  P. Ganz,et al.  Karnofsky performance status revisited: reliability, validity, and guidelines. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[83]  M. C. Karamchandani,et al.  Vesicoenteric fistulas. , 1984, American journal of surgery.

[84]  E. McFadden,et al.  Toxicity and response criteria of the Eastern Cooperative Oncology Group , 1982, American journal of clinical oncology.

[85]  A. Miller,et al.  Reporting results of cancer treatment , 1981, Cancer.

[86]  H. Bussey.  Polyposis syndromes. , 1978, Major problems in pathology.

[87]  P. Chretien,et al.  Effect of age and cigarette smoking on carcinoembryonic antigen levels. , 1976, JAMA.

[88]  Peter J. E. Cruse,et al.  A five-year prospective study of 23,649 surgical wounds. , 1973, Archives of surgery.

[89]  Romeo S. Berardi.  Carcinoid tumors of the colon (exclusive of the rectum): Review of the literature , 1972, Diseases of the colon and rectum.

[90]  C. Heidelberger,et al.  Fluorinated pyrimidines. XXVI. Mammalian thymidylate synthetase: its mechanism of action and inhibition by fluorinated nucleotides. , 1965, Molecular pharmacology.

[91]  Phil Gold,et al.  DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES , 1965, The Journal of experimental medicine.

[92]  A. Bornstein,et al.  Carcinoid Tumors , 2006 .